Bruce G. Allen Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
266
+24
+10% +$1.3K 0.01% 473
2026
Q1
$15.2K Hold
242
– – 0.01% 436
2025
Q4
$23.1K Hold
242
– – 0.02% 383
2025
Q3
$23.6K Hold
242
– – 0.02% 377
2025
Q2
$26K Sell
242
-44
-15% -$4.45K 0.02% 352
2025
Q1
$28.9K Sell
286
-153
-35% -$15.4K 0.02% 332
2024
Q4
$39.2K Hold
439
– – 0.03% 292
2024
Q3
$36.8K Sell
439
-132
-23% -$10.4K 0.03% 310
2024
Q2
$44K Buy
571
+89
+18% +$6.51K 0.04% 262
2024
Q1
$33K Hold
482
– – 0.03% 309
2023
Q4
$27.9K Buy
+482
New +$25.7K 0.03% 329

Other funds holding BSX

Bruce G. Allen Investments's BSX Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Boston Scientific (BSX) stake by 9.9% in Q2 2026, buying an estimated $1.3K and bringing the position to 266 shares worth $11.4K. The position accounts for 0.01% of the portfolio, ranked #473.

Bruce G. Allen Investments first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $44K in Q2 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bruce G. Allen Investments held 266 shares of Boston Scientific worth $11.4K as of Q2 2026.
  • Bruce G. Allen Investments bought 24 Boston Scientific shares in Q2 2026, an estimated $1.3K.
  • Boston Scientific made up 0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #473 holding.
  • Bruce G. Allen Investments first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Boston Scientific position peaked at $44K in Q2 2024.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.